Back
Nuveen AMT-Free Quality Municipal Income Fund Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
71
NEA
Nuveen AMT-Free Quality Municipal Income Fund
Last Price:
$11.71
Seasonality Move:
0.54%
Sell
45
LYEL
Lyell Immunopharma, Inc.
Last Price:
$32.00
Seasonality Move:
-22.7%
Buy
71
Nuveen AMT-Free Quality Municipal Income Fund (NEA)
is a Buy
Is Nuveen AMT-Free Quality Municipal Income Fund a Buy, Sell or Hold?
-
The current Nuveen AMT-Free Quality Municipal Income Fund [NEA] share price is $11.70. The Score for NEA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NEA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $31.59. The Score for LYEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NEA Stock Price Chart
What is Nuveen AMT-Free Quality Municipal Income Fund's stock price today?
-
The Nuveen AMT-Free Quality Municipal Income Fund share price today is $11.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NEA is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $31.59The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
NEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 60.94 | Buy |
| Chaikin Money Flow: | 1276544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.49 - 11.63) | Buy |
| Bollinger Bands (100): | (11.1 - 11.6) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | -97541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.36 - 35.26) | Buy |
| Bollinger Bands (100): | (10.99 - 25.97) | Buy |
NEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.58 | Buy |
| 20-day SMA: | 11.58 | Buy |
| 50-day SMA: | 11.54 | Buy |
| 200-day SMA: | 11.12 | Buy |
| 8-day EMA: | 11.6 | Buy |
| 20-day EMA: | 11.57 | Buy |
| 50-day EMA: | 11.35 | Buy |
| 200-day EMA: | 7.44 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Sell |
| 20-day SMA: | 31.47 | Buy |
| 50-day SMA: | 23.56 | Buy |
| 200-day SMA: | 14.09 | Buy |
| 8-day EMA: | 34.44 | Sell |
| 20-day EMA: | 31.53 | Buy |
| 50-day EMA: | 25.65 | Buy |
| 200-day EMA: | 18.32 | Buy |
Nuveen AMT-Free Quality Municipal Income Fund Earnings Growth & NEA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
Nuveen AMT-Free Quality Municipal Income Fund Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||